Brief: Hart Q3 loss per share $0.19
Nov 12 (Reuters) - Harvard Apparatus Regenerative Technology Inc HART.O : * Hart reports Q3 financial results and provides business update * Q3 loss per share $0.19 * Source text for Eikon ID:nPn7lZsD5 * Further company coverage HART.O ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on Harvard Apparatus Regenerative Technology
See all newsBrief: Harvard Apparatus Regenerative Technology Announces Strategic Collaboration With Children’S Hospital Capital Institute Of Pediatrics In Beijing, China To Advance Treatment For Esophageal Atresia
Brief: Biostage Activated Mayo Clinic As The First Site For Clinical Trial In Severe Esophageal Disease
Brief: Biostage Amends CEO Employment Agreement
Brief: Biostage Inc Files For Firm Commitment Public Offering Of 1.03 Million Units - SEC Filing
Brief: Biostage Announces Appointment Of New Chief Financial Officer